Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.3174 (-3.79%) ($0.3174 - $0.3174) on Fri. May. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.54% (three month average) | RSI | 38 | Latest Price | $0.3174(-3.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -5.7% a day on average for past five trading days. | Weekly Trend | ANPC declines -8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) REMX(83%) EWG(75%) XLE(61%) USO(60%) SPY(55%) | Factors Impacting ANPC price | ANPC will decline at least -5.27% in a week (0% probabilities). SHY(-32%) VCSH(-28%) BND(-22%) BNDX(-20%) LQD(-15%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.27% (StdDev 10.54%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.38 | 5 Day Moving Average | $0.33(-3.82%) | 10 Day Moving Average | $0.33(-3.82%) | 20 Day Moving Average | $0.38(-16.47%) | To recent high | -65.2% | To recent low | 11.4% | Market Cap | $3m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |